Dr. Yanosh Zilioli is a movement disorder specialist and cognitive neurologist at the Barrow Neurological Institute in Phoenix, Arizona. He holds both MD and PhD degrees and specializes in the diagnosis and treatment of atypical parkinsonian disorders including progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS). His expertise extends to deep brain stimulation (DBS) programming and therapeutic clinical trials for tauopathies.
Dr. Zilioli's clinical practice at the Muhammad Ali Parkinson Center (part of Barrow Neurological Institute) serves as a major referral center for patients with atypical parkinsonism from across the southwestern United States. His research combines clinical observation with translational work aimed at developing better diagnostic markers and therapies for these devastating disorders.
Dr. Zilioli's clinical and research work focuses on:
Dr. Zilioli provides specialized care for patients with:
This study characterized the spectrum of clinical presentations in CBS, identifying phenotypic variations that may correlate with underlying pathology and prognosis.
Analysis of PSP subtypes and their progression patterns in the southwestern United States population, contributing to understanding of regional and ethnic variations.
Investigation of DBS efficacy and optimal programming strategies for patients with atypical parkinsonian disorders.
Dr. Zilioli has contributed to consensus diagnostic criteria:
Longitudinal observational study of PSP and CBS patients at Barrow Neurological Institute, collecting clinical, imaging, and biological data to characterize disease progression and identify biomarkers.
Research focused on optimizing deep brain stimulation parameters for patients with atypical parkinsonism, including target selection (STN vs GPi) and stimulation settings.
Active participation in clinical trials for investigational therapies:
Dr. Zilioli is involved in training the next generation of movement disorder specialists: